Literature DB >> 4016054

Hyaluronate increases intraocular pressure when used in cataract extraction.

M S Passo, J T Ernest, T K Goldstick.   

Abstract

A prospective randomised study of 26 eyes (24 patients) following uncomplicated intracapsular cataract surgery was carried out with three groups in which different agents were used to re-form the anterior chamber: air, seven eyes; sodium hyaluronate, seven eyes; and a combination of hyaluronate plus systemic acetazolamide, 12 eyes. The intraocular pressure (IOP) was measured by Goldmann applanation tonometry 16 hours before surgery and every eight hours after surgery for 72 hours. The IOP doubled in the two hyaluronate-treated groups for the first day following cataract surgery. By contrast, the IOP in the group receiving air initially decreased slightly. Throughout the study the effect of using acetazolamide was never statistically significant. After the first day and a half the differences in IOP among the three treatment groups disappeared, and the pressures returned to their preoperative values.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4016054      PMCID: PMC1040681          DOI: 10.1136/bjo.69.8.572

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  22 in total

1.  Effect of the intraocular lens on intraocular pressure.

Authors:  J A Smith; D R Anderson
Journal:  Arch Ophthalmol       Date:  1976-08

2.  Early ocular hypertension after cataract extraction.

Authors:  W J Rich; N D Radtke; B E Cohan
Journal:  Br J Ophthalmol       Date:  1974-08       Impact factor: 4.638

3.  Blood-aqueous barrier and alpha-chymotrypsin glaucoma in rabbits.

Authors:  D Sears; M Sears
Journal:  Am J Ophthalmol       Date:  1974-03       Impact factor: 5.258

4.  The use of sodium hyaluronate (Healon) in human anterior segment surgery.

Authors:  L G Pape; E A Balazs
Journal:  Ophthalmology       Date:  1980-07       Impact factor: 12.079

5.  Distribution of acid phosphatase, beta-glucuronidase, and lysosomal hyaluronidase in the anterior segment of the rabbit eye.

Authors:  S Hayasaka; M L Sears
Journal:  Invest Ophthalmol Vis Sci       Date:  1978-10       Impact factor: 4.799

6.  Use of Na-hyaluronate in anterior segment eye surgery.

Authors:  D Miller; R Stegmann
Journal:  J Am Intraocul Implant Soc       Date:  1980-01

7.  Inflammation and intraocular pressure after the use of Healon in intraocular lens surgery.

Authors:  C D Binkhorst
Journal:  J Am Intraocul Implant Soc       Date:  1980-10

8.  The protective effect of Na-hyaluronate to corneal endothelium.

Authors:  E L Graue; F M Polack; E A Balazs
Journal:  Exp Eye Res       Date:  1980-07       Impact factor: 3.467

9.  Hyaluronic acid and replacement of vitreous and aqueous humor.

Authors:  E A Balazs; M I Freeman; R Klöti; G Meyer-Schwickerath; F Regnault; D B Sweeney
Journal:  Mod Probl Ophthalmol       Date:  1972

10.  Experimental alpha chymotrypsin glaucoma studied by scanning electron microscopy.

Authors:  D R Anderson
Journal:  Am J Ophthalmol       Date:  1971-02       Impact factor: 5.258

View more
  4 in total

1.  Intraocular pressure rise after small incision cataract surgery: a randomised intraindividual comparison of two dispersive viscoelastic agents.

Authors:  G Rainer; R Menapace; O Findl; B Kiss; V Petternel; M Georgopoulos; B Schneider
Journal:  Br J Ophthalmol       Date:  2001-02       Impact factor: 4.638

2.  Acute pulmonary oedema due to single dose acetazolamide taken after cataract surgery.

Authors:  Suzan Guven Yilmaz; Melis Palamar; Cemil Gurgun
Journal:  BMJ Case Rep       Date:  2016-05-11

3.  Oral versus topical carbonic anhydrase inhibitors in ocular hypertension after scleral tunnel cataract surgery.

Authors:  Abdulmoghni Al-Barrag; Motaher Al-Shaer; Nabil Al-Matary; Mahfoud Bamashmous
Journal:  Clin Ophthalmol       Date:  2009-06-29

Review 4.  Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing.

Authors:  K L Goa; P Benfield
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.